Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
AXSM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 0.07%43.950.0%$502.77m
VRXValeant Pharmaceuticals International, Inc. -2.10%27.5714.1%$162.23m
CTLTCatalent, Inc. -0.18%138.012.0%$138.57m
ICLRICON plc 2.93%270.742.8%$114.50m
INDPIndaptus Therapeutics, Inc. 7.72%11.580.0%$94.88m
HZNPHorizon Therapeutics Plc 1.77%107.955.5%$94.45m
JAZZJazz Pharmaceuticals Plc -1.10%131.742.1%$90.81m
PRGOPerrigo Co. Plc -1.64%44.356.9%$77.73m
ARGXargenx SE 0.58%323.580.0%$55.61m
ENDPEndo International Plc -3.89%2.728.5%$52.09m
BHCBausch Health Cos., Inc. -2.10%27.570.0%$51.15m
AXSMAxsome Therapeutics, Inc. 2.92%28.531.8%$51.10m
UTHRUnited Therapeutics Corp. 0.43%205.1414.0%$48.94m
SNOASonoma Pharmaceuticals, Inc. 0.76%5.313.4%$33.03m
ENVBEnveric Biosciences, Inc. 2.64%2.720.0%$22.38m

Company Profile

Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.